Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Return on Invested Capital (2020 - 2023)

Tarsus Pharmaceuticals (TARS) has 4 years of Return on Invested Capital data on record, last reported at 0.52% in Q2 2023.

  • For Q2 2023, Return on Invested Capital fell 25.0% year-over-year to 0.52%; the TTM value through Jun 2023 reached 0.52%, down 25.0%, while the annual FY2025 figure was 0.21%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.52% in Q2 2023 per TARS's latest filing, down from 0.33% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.02% in Q2 2021 and bottomed at 0.52% in Q2 2023.
  • Average Return on Invested Capital over 4 years is 0.23%, with a median of 0.27% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: grew 29bps in 2021, then dropped -25bps in 2022.
  • A 4-year view of Return on Invested Capital shows it stood at 0.36% in 2020, then skyrocketed by 81bps to 0.07% in 2021, then crashed by -309bps to 0.29% in 2022, then plummeted by -79bps to 0.52% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.52% in Q2 2023, 0.33% in Q1 2023, and 0.29% in Q4 2022.